Astex Pharmaceuticals, Inc. (NASDAQ: ASTX), a pharmaceutical company dedicated to the discovery and development of novel therapeutics, today announced that James S.J. Manuso, Ph.D., chairman and chief executive officer, will present at Biotech Showcase 2012 on Monday, January 9th in San Francisco.
The Company's presentation will begin at 3:00 p.m. PT. A live webcast of the presentation will be available in the Investor Events section of the Company's website, www.astx.com. The webcast will be archived for 30 days.
About Astex Pharmaceuticals
Astex Pharmaceuticals is dedicated to the discovery and development of novel therapeutics with a focus on oncology. The Company is developing a proprietary pipeline of novel therapies and is creating de-risked products for partnership with leading pharmaceutical companies. Astex Pharmaceuticals developed Dacogen® (decitabine) for Injection and receives significant royalties on global sales.
For more information about Astex Pharmaceuticals, Inc., please visit http://www.astx.com.
Astex Pharmaceuticals, Inc.
Timothy L. Enns
Senior Vice
President
Corporate Communications & Marketing
Tel: (925)
560-2810
E-mail: tim.enns@astx.com
or
Astex
Pharmaceuticals, Inc.
Susanna Chau
Manager
Investor
Relations
Tel: (925) 560-2845
E-mail: susanna.chau@astx.com
or
The
Trout Group
Alan Roemer
Managing Director
Tel:
(646) 378-2945
E-mail: aroemer@troutgroup.com
or
College
Hill
Melanie Toyne-Sewell (Europe)
Rebecca Skye
Dietrich (US)
Tel: +44 20 7866 7866
Tel: (857) 241-0795
E-mail:
astex@collegehill.com